CTRE Company Profile and Key Details

Short-term trend indicators are bearishly aligned (SMA20 5.13%, SMA50 9.0%, SMA200 20.29%). The stock’s 14-day RSI is 68.47 (firm momentum), while the ATR of 0.89 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -0.53% below its high and over 61.46% above its low. Average 10-day trading volume of 1.77 million shares is below the 3-month average of 2.52 million, indicating normal recent market interest.

CareTrust REIT, Inc. generated EPS of $1.55 over the past year. Five-year average earnings growth is 13.11%. Wall Street analysts project EPS growth of 2.86% annually over the next five years. The latest quarter delivered EPS of $0.38. The next quarter is forecast at $0.36. Next year's EPS is expected at $95.69. Analyst sentiment is bullish. Analyst rating data shows there are 12 Strong Buy ratings, 4 Buy ratings, 2 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $48.00 to $37.00. The high target offers 23.05% upside. The low target suggests -5.15% downside. The mean target is $43.11. This offers 10.51% upside. CareTrust REIT, Inc. earnings surprise history is a mixed track record. The quarter that ended August 06, 2026, missed forecasts by -1.04%. The prior quarter beat by 1.84%. Over the last six quarters, Apple has recorded several small beats. These include -2.33% in May 01, 2025.

CareTrust REIT, Inc. has 236.29 million shares outstanding. The public float is 234.38 million shares, elevated short interest at 12.29% of float. This equals 24.29 million shares. The short ratio is 10.96 days. Institutional investors hold 102.18% of the float. Insiders own 0.78%. Christensen Christopher R. holds 1.11 million shares, Wagner William M has 257.44 thousand shares and Stapley Gregory K. has 205.02 thousand shares.

CareTrust REIT, Inc. last paid a dividend of 1.45 per share, this equals a trailing yield of roughly 3.98%. Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $94.25. This means the shares are trading below this model’s fair value.

CareTrust REIT, Inc. (NYSE:CTRE) closed at $39.01 USD, losing -$0.60 (-1.51%) from the previous close of $39.61. The stock is currently mid-range between its 52-week high and low $32.79 and $43.62. With a market capitalization of about $9.22 billion, CareTrust REIT, Inc. is classified as a mid-cap and shows market-like volatility (beta ~0.80). Key stats such as the average daily volume over the past year has been around 2.69 million shares, volume is running light vs its 52-week average. Headquartered in Dana Point, CA, CareTrust REIT, Inc. operates in the Real Estate sector and the REIT - Healthcare Facilities industry. Led by CEO David Sedgwick, the company employs approximately 43 people and listed since May 29, 2014. CareTrust REIT, Inc. operates as a self-managed, publicly traded real estate investment trust.

CareTrust REIT, Inc. trades at a P/E ratio of 24.32, slightly below the S&P 500 average, with a price-to-sales ratio of 17.02 and a price-to-book ratio of 2.04 suggesting the stock is closer to book value. The P/FCF stands at 21.45, also above market averages.

CareTrust REIT, Inc. (NYSE:CTRE) shares are flat 3.29% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows CareTrust REIT, Inc. trading at a premium to the broader market with a P/E of 24.32. Analyst sentiment is bullish, with the majority of ratings in Overweight territory and a mean price target of $30.49, suggesting -21.84% downside. Our AI forecast model points to short-term strength (1.72% over two weeks), a medium-term rise (1.1% over three months), and a longer-term gain (21.15% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that CareTrust REIT, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 1.72%, with price expected at $39.68 by September 17, 2026, within a range of $38.90 to $40.49 3-Month Outlook: Projected rise of 1.1%, reaching $39.44 by December 02, 2026, with a range of $39.07 to $39.80. 1-Year Outlook: Projected gain of 21.15%, with price at $47.26 by September 03, 2027, within a range of $46.47 to $47.98.